FDA Investigator

Azeezat M Lawal

Latest inspection on record: Allentown, United States, April 2026 · records back to 2023

Human Drugs

FDA inspection record · Last updated July 12, 2026

Overview

  • 13 inspections across 13 sites are on record.
  • 28 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-04-24.

At a glance

Inspections

13

Sites

13

Observations

28

Career since

Dec 2023

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Fragrance Manufacturing, Inc.24 Apr 2026Human DrugsView 483 →
EMS Acquisition Corp24 Oct 2025Human DrugsView 483 →
Schwabe North America, Inc.28 Aug 2025Human DrugsView 483 →
Fareva Richmond, Inc.23 May 2025Human DrugsView 483 →
EMINENT Services Corporation28 Apr 2025Human DrugsView 483 →

Sites inspected

Fragrance Manufacturing, Inc.Allentown, United States1 insp.
EMS Acquisition CorpMorgantown, United States1 insp.
Schwabe North America, Inc.Green Bay, United States1 insp.
Fareva Richmond, Inc.Henrico, United States1 insp.
EMINENT Services CorporationFrederick, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Yaharn Su3 shared
Nelson N Ayangho2 shared
Michael O Idowu1 shared
Ogechi C Nna1 shared

Full investigator report

Get the verbatim findings behind Azeezat M Lawal's 28 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site